Inicio・Lista de Acciones・Ocugen Inc

Ocugen Inc

Cerrado

1.27 4.96

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

1.24

Máximo

1.31

Métricas clave
By Trading Economics
Ingresos	-1.5M -19M
Ventas	1.7M 1.5M
BPA	-0.06
Margen de beneficios	-1,250.946
Empleados	116
EBITDA	-987K -17M

Recomendaciones
By TipRanks
Recomendaciones	Compra Fuerte
Estimación a 12 Meses	+667.46% upside

Dividendos
By Acuity
Próximas Ganancias	31 jul 2026

Estadísticas de Mercado
By TradingEconomics
Capitalización Mercado	-176M 450M
Apertura anterior	-3.69
Cierre anterior	1.27

Ocugen Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

27 jul 2026, 23:56 UTC

eBay Inc. shares are trading lower in after-market hours, with no specific company news identified. The stock remains near the midpoint of its one-month trading range.

27 jul 2026, 23:56 UTC

Steel Dynamics Inc shares are trading lower in after-market hours. No specific company news was identified to explain the price movement.

27 jul 2026, 23:56 UTC

Alibaba Group Holding Ltd shows a slight gain in after-market trading, reflecting positive market sentiment. The stock remains above its 20-day moving average.

27 jul 2026, 23:56 UTC

PepsiCo Inc. shares remained roughly flat during after-market hours, trading within a narrow range around the middle of their one-month range.

27 jul 2026, 23:56 UTC

Monday.Com Ltd. shares are lower in after-market trading, fluctuating within a narrow range without specific news driving the decline.

27 jul 2026, 23:56 UTC

Correlated Moves

Kulicke and Soffa Industries shares declined in after-market trading, reflecting broader weakness in the semiconductor sector and a drop in the Nasdaq 100 Index.

27 jul 2026, 23:56 UTC

Madrigal Pharmaceuticals Inc is trading higher in after-market hours, reflecting a notable increase since Monday's close, despite no specific news identified.

27 jul 2026, 23:56 UTC

Correlated Moves

News

Diamondback Energy gained during after-market hours, buoyed by strong revenue growth and a favorable market position, with shares peaking above Monday's close.

27 jul 2026, 23:56 UTC

Under Armour Inc shares are lower in after-market trading, with no specific news identified to explain the decline. The stock remains above its 20-day moving average.

27 jul 2026, 23:56 UTC

Whirlpool Corp shares are higher in after-market hours, reflecting a modest increase since Monday's close amid positive sentiment in European markets.

27 jul 2026, 23:56 UTC

Archer-Daniels-Midland Co is rising in after-market trading, reversing three sessions of declines. No specific news was identified to explain this movement.

27 jul 2026, 23:56 UTC

Matador Resources Co shares are higher in after-market trading following Monday's close, despite remaining below their 20-day moving average.

27 jul 2026, 23:56 UTC

JD.Com Inc. shares declined in after-market trading, despite a strong one-month gain and trading above its 20-day moving average. No specific news was identified.

27 jul 2026, 23:56 UTC

Correlated Moves

Costco shares are lower in after-market trading, following a slight decline in the Nasdaq 100 Index. The stock remains above its 20-day moving average.

27 jul 2026, 23:56 UTC

Social Media

General Motors plans a $6 billion investment in U.S. manufacturing, including an expansion at its Orion Township plant. Shares are roughly flat in after-market trading.

27 jul 2026, 23:56 UTC

Shell PLC shares showed little change in after-market trading. The stock remains above its 20-day moving average amid positive sentiment in European markets.

27 jul 2026, 23:56 UTC

Viking Therapeutics Inc shares are lower in after-market hours, reflecting a lack of specific news and remaining below the 20-day moving average.

27 jul 2026, 23:56 UTC

Trimble Inc shares are lower in after-market hours following Monday's close. The stock remains above its 20-day moving average despite the decline.

27 jul 2026, 23:52 UTC

Mexico's Business Confidence Data Release on August 3, 2026, Expected to Reflect Cautious Sentiment Amid Global Market Volatility and Inflationary Pressures.

27 jul 2026, 23:52 UTC

U.S. Initial Jobless Claims Expected at 204,000 Amid Positive Labor Market Sentiment and Fed Policy Speculation

27 jul 2026, 23:52 UTC

Australia's Building Permits Expected to Decline by 0.5% in June Amidst Ongoing Weakness in Housing Construction and Elevated Borrowing Costs

27 jul 2026, 23:52 UTC

Weis Markets shares declined after-market, remaining about 4.47% below their 20-day moving average. No specific news was identified to explain the movement.

27 jul 2026, 23:52 UTC

Xylem Inc shares are higher in after-market trading, continuing a trend of four consecutive sessions of gains and remaining above the 20-day moving average.

27 jul 2026, 23:51 UTC

Trustmark Corp shares are higher during after-market hours, moving from a low of -0.04% to a high of 0.95% since Monday's close.

27 jul 2026, 23:51 UTC

Correlated Moves

Vanguard Total Bond Market ETF trades higher after-market, reflecting broader market trends amid easing geopolitical tensions and a drop in oil prices.

27 jul 2026, 23:51 UTC

J B Hunt Transport Services Inc shares are lower in after-market hours, continuing a downward trend with no specific news identified to explain the movement.

27 jul 2026, 23:51 UTC

Social Media

Correlated Moves

Shares lower in after-market trading; call writer profits $1.28 million.

27 jul 2026, 23:51 UTC

Regeneron Pharmaceuticals shares are higher in after-market trading, maintaining momentum with strong cumulative returns and three consecutive higher daily closes.

27 jul 2026, 23:51 UTC

News

Event

UDR Inc reported second-quarter net income of $69.035 million. Shares declined in after-market trading amid concerns over flat revenue and rising costs.

27 jul 2026, 23:51 UTC

News

L3Harris Technologies has secured Pentagon agreements to boost missile defense production, but shares are trading lower in after-market hours.

Comparación entre iguales

Cambio de precio

Ocugen Inc previsión

Precio Objetivo

By TipRanks

667.46% repunte

Estimación a 12 Meses

Media 9.67 USD 667.46%

Máximo 12 USD

Mínimo 7 USD

De acuerdo con 6 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Ocugen Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

6 ratings

Comprar

Mantener

Vender

De acuerdo con 6 analistas que ofrecen calificaciones bursátiles a para Ocugen Inc Dist en los últimos 3 meses.

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

Acerca de Ocugen Inc

Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve patients' health. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, currently under Phase 3 trials for the treatment of retinitis pigmentosa and Phase 1/2 trials for the treatment of leber congenital amaurosis; OCU410, a gene therapy under phase 1/2 for the treatment of dry age-related macular degeneration (AMD); and OCU410ST, a gene therapy under phase 1/2 for the treatment of Stargardt disease. It is also involved in the development of OCU200, a novel fusion protein that is in preclinical development stage for the treatment of diabetic macular edema, diabetic retinopathy, and wet age-related macular degeneration; and NeoCart, an autologous chondrocyte-derived neocartilage, currently under Phase 3 studies indicated for the repair of knee cartilage injuries in adult. In addition, the company is developing OCU500, a COVID-19 vaccine; OCU510, a seasonal quadrivalent flu vaccine; and OCU520, a combination quadrivalent seasonal flu and COVID-19 vaccine. It has collaboration agreements with National Institute of Allergy and Infectious Diseases for early clinical studies for the OCU500 program; and a strategic partnership with CanSino Biologics Inc. for manufacturing its modifier gene therapy pipeline product candidates. The company was founded in 2013 and is headquartered in Malvern, Pennsylvania.